Congratulations 👏👏 Dr. Javier Neyra Javier Neyra from UAB Nephrology for his receipt of a Notice of Award for a new R01 titled “Artificial Intelligence to Predict Outcomes in Patients with Acute Kidney Injury on Continuous Renal Replacement Therapy.”👏👏

Very touching

Festejando gran grupo !!!! SLAHN 2023 !!!!!

"The way AKI impacts Argentina is related to the unique features of a vast country." This Global Perspective analyzes the current clinical situation of patients with AKI in different settings and their access to therapy in Argentina bit.ly/KID0140 Rafael Avila

Yo también

I respect everybody’s opinion but being ICM a physiology-based specialty, where the north is to try to personalize management due to the extreme heterogeneity of our pts, it is perplexing how worldwide experts still believe that responses will be found in metaanalyses and EBM!

Today we honor Cleveland Clinic heart surgeon René Favaloro on what would have been his 100th birthday. Dr. Favaloro introduced coronary artery bypass surgery into clinical practice. It's a procedure that has saved countless lives since.

Prison For Crimes against humanity To wit: The forced sterilization of children Where are you United Nations Oh yes Pushing the chicken little Climate agenda

Y algunos se quejan de las toses…

Miss you

Al que le gusta la ópera !!! Se viene radicuchini … como coti nada fue un error 😩

Algunos algun dia le llegara la justicia divina !!! Universidad publica siempre

Esto pareceria significar la palabra soberbio !!! La mejor de todas

Wow! Great news for the #PAH community! The #ZENITH clinical trial meets primary endpoint at interim analysis and adds data supporting the use of #sotatercept. An immense honor to be part of this team. Vallerie McLaughlin U-M Health Frankel CVC Michigan Medicine

Great work Víctor !!! Congratulations

My highlights Sotatercept in severe PAH (ZENITH - NEJM): + 76% risk reduction (death/transplant/hospitalization) + Improves WHO class & biomarkers − Nosebleeds, telangiectasias − Short trial, selective population Bottom line: promising add-on therapy nejm.org/doi/full/10.10…

Dear friends and colleagues, It is with overwhelming sadness that we share news of the death of our colleague, mentor and friend, Rinaldo Bellomo. During recent days, both he and his family have received dedicated, expert and compassionate care from some of the finest in our ICU